Heparin-binding epidermal growth factor-like growth factor protects mesenchymal stem cells

Area of Science:

• Stem cell biology
• Regenerative medicine
• Gastroenterology

Background:

• Mesenchymal stem cells (MSCs) protect the intestines in ischemia/reperfusion injury models.
• Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a known intestinal cytoprotective agent.
• Previous work suggests HB-EGF acts on stem cells to confer protection.

Purpose of the Study:

• To investigate the effects of HB-EGF on amniotic fluid (AF)-derived MSCs and bone marrow (BM)-derived MSCs in vitro.
• To determine if HB-EGF influences MSC proliferation, migration, and survival.

Main Methods:

• AF-MSCs and BM-MSCs were isolated and cultured.
• Cells were incubated with HB-EGF.
• Proliferation, chemotaxis, and apoptosis were assessed under normoxic and anoxic conditions.

Main Results:

• HB-EGF significantly increased proliferation and migration of both AF-MSCs and BM-MSCs.
• HB-EGF provided significant protection against anoxia-induced apoptosis for both MSC types.
• The effects of HB-EGF were more pronounced in AF-MSCs compared to BM-MSCs.

Conclusions:

• HB-EGF functions as a mitogenic and chemotactic agent for MSCs.
• HB-EGF protects MSCs from cellular injury.
• These findings support the potential use of HB-EGF in MSC-based therapies for intestinal protection.